Several national and European Union variation applications have been received to change the wording of the recommendation of the use of non-steroidal anti-inflammatory medicines during pregnancy, according to the minutes of the most recent meeting of the European Medicines Agency’s Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) on 25-27 January 2022.
The submissions are based on a recent US Food and Drug Administration recommendation to avoid the use of NSAIDs in...
